[Federal Register Volume 82, Number 22 (Friday, February 3, 2017)]
[Notices]
[Page 9223]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02340]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-718 (Fourth Review)]


Glycine From China; Determination

    On the basis of the record \1\ developed in the subject five-year 
review, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that revocation of the antidumping duty order on glycine from 
China would be likely to lead to continuation or recurrence of material 
injury to an industry in the United States within a reasonably 
foreseeable time.
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission, pursuant to section 751(c) of the Act (19 U.S.C. 
1675(c)), instituted this review on August 1, 2016 (81 FR 50547) and 
determined on November 4, 2016 that it would conduct an expedited 
review (81 FR 87589, December 5, 2016).
    The Commission made this determination pursuant to section 751(c) 
of the Act (19 U.S.C. 1675(c)). It completed and filed its 
determination in this review on January 31, 2017. The views of the 
Commission are contained in USITC Publication 4667 (January 2017), 
entitled Glycine From China: Investigation No. 731-TA-718 (Fourth 
Review).

    By order of the Commission.

    Issued: January 31, 2017.
Katherine M. Hiner,
Acting Supervisory Attorney.
[FR Doc. 2017-02340 Filed 2-2-17; 8:45 am]
 BILLING CODE 7020-02-P